PIERIS PHARMACEUTICALS, INC.
PIERIS PHARMACEUTICALS, INC. (PIRS) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 67 transactions totaling $29.2M, demonstrating a bearish sentiment with -$22.5M in net insider flow. The most recent transaction on Aug 12, 2024 involved a purchase of 2,243 shares valued at $35.6K.
PIRS Insider Activity Summary
Who Is Buying PIRS Stock?
No significant insider buying has been recorded for PIRS in the recent period.
Who Is Selling PIRS Stock?
No significant insider selling has been recorded for PIRS in the recent period.
Is PIERIS PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PIRS is bearish with an Insider Alignment Score of 11/100 and a net flow of -$22.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PIRS Frequently Asked Questions
Understanding PIRS Insider Activity
Insider trading at PIERIS PHARMACEUTICALS, INC. (PIRS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading PIRS stock, having executed 67 transactions in the past 90 days. The most active insider is Samuel D. Isaly (Executive), who has made 4 transactions totaling $13.9M.
Related Tools
Track PIERIS PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at PIRS file new Form 4 transactions